Young survivors explain what it’s like getting back to ‘normal’ after cancer 
August 25, 2017
Researchers Lead New Effort to Prevent HIV, Hepatitis C Outbreaks Related to Opioid Epidemic
August 28, 2017
Show all

From cancer evolution to personalized therapies

Personalized cancer therapy is making progress.

Being able to predict the resistance or sensitivity of a tumour cell to a drug is a key success-factor of cancer precision therapy. But such a prediction is made difficult by the fact that genetic alterations in tumours change dynamically over time and are often interdependent, following a pattern that is poorly understood. A recent study led by researchers at the SIB Swiss Institute of Bioinformatics, University of Lausanne and EPFL provides a promising framework to anticipate drug resistance in cancer, by predicting the co-occurrence of about 500 known tumour alterations, as well as their response to over 200 common cancer drugs. The research, published in Cancer Cell, showed that while some co-occurrences between genomic alterations confer a resistance to tumour cells against particular drugs, they also make them sensitive to other unexpected drugs.

Read full article: SIBWeb – From cancer evolution to personalized therapies

Read Full Article: SIBWeb – From cancer evolution to personalized therapies

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.